论文部分内容阅读
Ziprasidone盐酸盐是用于治疗精神分裂症的药物 ,该产品于 2 0 0 1年初经美国 FDA批准上市。值得一提的是 ,该药的使用说明书上不需标注要求使用者接受心电图监测的有关提醒。Ziprasidone盐酸盐是一类新的多巴胺 D2 受体的拮抗剂 ,它与中枢系统多巴胺 D2 受体的亲和力是与 5-羟
Ziprasidone hydrochloride is a drug used to treat schizophrenia, which was approved by the U.S. FDA in early 2001. It is worth mentioning that the instructions for the drug need not be marked on the user to receive ECG reminders. Ziprasidone hydrochloride is a new class of dopamine D2 receptor antagonists whose affinity for the central dopamine D2 receptor is 5-hydroxy